Form 4: Lifecore Biomedical Director Jeffrey Edwards Acquires 30,000 Shares of Common Stock

Director Jeffrey Edwards acquired 30,000 shares of Lifecore Biomedical, Inc. common stock on July 8, 2024.

Summary

• On July 8, 2024, Jeffrey L Edwards, a director of Lifecore Biomedical, Inc., acquired 30,000 shares of common stock.
• The shares were acquired in the form of restricted stock units that convert into common stock on a 1-for-1 basis.
• Following the transaction, Edwards directly owns 79,667 shares of Lifecore Biomedical, Inc.
• The restricted stock units vest on the earlier of the first anniversary of the grant date or the date of the annual meeting of stockholders first held in calendar year 2025, subject to potential acceleration.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock acquisition by a director. While insider buying can be seen as positive, it's not a strong indicator on its own.

Positives

• A director's acquisition of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The restricted stock units vest on the earlier of the first anniversary of the grant date or the date of the annual meeting of stockholders first held in calendar year 2025, subject to potential acceleration.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates